Rising demand for monoclonal antibodies, recombinant proteins, and gene therapies accelerates outsourcing to specialized CROs and CDMOs worldwide.Austin, Dec. 12, 2025 (GLOBE NEWSWIRE) -- As per SNS ...
Continued Mpox Evolution Underscores Dependence on a Single Global Supplier, Reinforcing the Critical Importance of GeoVax's ...
According to doctors, the discovery of the strain is "precisely what experts in the field feared would happen" ...
Norovirus is the leading cause of gastroenteritis and is responsible for hundreds of thousands of deaths every year. However, ...
DENVER, Dec. 10, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market ...
Harmony Baby Nutrition has secured R$31.8M ($5.8M) from the Brazilian government to create breast-milk-inspired infant ...
A hybrid form of mpox has been identified in the UK. Health professionals are not surprised that the sexually transmitted ...
On November 25, 2025, Sarepta Therapeutics filed two petitions for inter partes review (“IPR”) challenging Genzyme’s patents relating to ...
A newly identified mpox strain detected in England has triggered a rapid review by British health authorities as scientists ...
Researchers from The University of Osaka have developed a novel reverse genetics system to study norovirus, the leading cause of gastroenteritis. This efficient system can generate infectious viral ...
A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...
Pharmaceutical Technology on MSN
Solid Biosciences’ SGT-212 gains FDA rare paediatric disease status
The designation enables sponsors to receive a paediatric priority review voucher.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback